FDA Approves YERVOY™ (ipilimumab)
25 March 2011 | By Bristol-Myers Squibb Company
For the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer...
List view / Grid view
News
Boehringer Ingelheim finalizes acquisition of AMGEN’s Fremont facility in the USA
Yesterday Boehringer Ingelheim formally acquired Amgen’s biopharmaceutical development and manufacturing facility in Fremont, California (USA)...
Hudson Robotics announces new easy-to-use interfaces for complex instruments
25 March 2011 | By Hudson Robotics, Inc.
Hudson Robotics announced the release of multiple interfaces for SoftLinx™ V software...
GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
23 March 2011 | By GlaxoSmithKline
GSK announced that it will no longer pursue global approval for the use of Avodart™...
Sanofi-aventis strengthens commitment to ophthalmology through partnership with the Vision Institute
23 March 2011 | By Sanofi-aventis
Sanofi-aventis announced the signing of a cooperation agreement between Fovea Pharmaceuticals & the Vision Institute...
PRECOS & Argenta extend collaboration to offer world class integrated oncology drug discovery services
22 March 2011 | By The Scott Partnership
PRECOS, has extended its alliance with Argenta...
Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China
22 March 2011 | By Novartis
Novartis announced that it completed the transaction to acquire an 85 percent stake in Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd...
Isogenica Ltd announces collaboration with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
22 March 2011 | By Limewash Media & Design Ltd
Isogenica Ltd today announced that it has executed a services agreement with J&JPRD...
Thermo Fisher Scientific adds new Atlas CDS software control for Shimadzu Prominence HPLC
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability of a new Thermo Scientific Atlas Chromatography Data System (CDS) instrument control software for the Shimadzu Prominence® and Prominence XR HPLC.
Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor in advanced basal cell carcinoma
21 March 2011 | By Roche
Roche today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results...
Novozymes Biopharma to present latest research on recombinant human albumin at AAPS
21 March 2011 | By The Scott Partnership
Novozymes Biopharma, announced a scientific poster on recombinant human albumin...
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment
21 March 2011 | By Novartis
The European Commission has granted Novartis approval for Gilenya®...
Almac & Exco InTouch form alliance to deliver patient compliance & ePRO services using multiple technologies
21 March 2011 | By The Scott Partnership
Almac's Clinical Technologies business unit, has formed alliance with Exco InTouch...
Sigma® Life Science launches suite of knockout rats to model Parkinson’s disease
17 March 2011 | By kdm communications limited
Inititive is in collaboration with The Michael J. Fox Foundation for Parkinson’s Research...
Can personalised medicine save the pharma sector?
17 March 2011 | By GDS International
Personalised medicine is making a comeback – but will it stick this time?...
